Standout Papers

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of ... 1997 2026 2006 2016 578
  1. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. (1997)
    Miljenko V. Pilepich, Richard Caplan et al. Journal of Clinical Oncology
  2. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate (2001)
    Miljenko V. Pilepich, Kathryn Winter et al. International Journal of Radiation Oncology*Biology*Physics

Immediate Impact

5 from Science/Nature 79 standout
Sub-graph 1 of 20

Citing Papers

Biologically informed deep neural network for prostate cancer discovery
2021 StandoutNature
The Magic of Randomization versus the Myth of Real-World Evidence
2020 Standout
3 intermediate papers

Works of J Mesić being referenced

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
2001 Standout
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.
1997 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
J Mesić 1490 418 400 13 1.8k
Varagur Venkatesan 1607 439 637 47 2.3k
Jaap Hoogenhout 1064 646 291 10 1.7k
Ignace Billiet 1649 429 371 37 2.0k
Jiho Nam 1306 529 1112 35 2.4k
L.E.C.M. Blank 1824 434 531 44 2.5k
P. Borasio 891 719 165 38 2.0k
Madhu J. John 1714 1105 372 44 2.3k
A.M. Cassoni 950 657 76 37 2.2k
J.H. Meerwaldt 869 414 193 41 1.8k
Jan Pruim 1213 268 126 19 1.7k

All Works

Loading papers...

Rankless by CCL
2026